In The News

  • Email
  • Print
  • Share
  • Text
Highlight Glossary Terms

News tagged ‘LungCancer’ clear

  • Lung cancer among younger, healthier, and non-smoking individuals "seems to be emerging as its own subtype of lung cancer — one for which new, powerful treatments are needed to make it a livable disease" said Dr. Geoffrey Oxnard, a lung cancer specialist at Dana-Farber Cancer Institute.

Tags: LungCancer, Genetics

  • Treated at Dana-Farber by Dr. David Jackman and Dr. Raymond Mak, reporter Bill Shields of WBZ-TV is now cancer free.

Tags: LungCancer

  • Dr. Pasi A. Jänne discusses a new study that demonstrates that chemotherapy and a new, targeted therapy work better in combination than chemotherapy alone in treating patients with the most common genetic subtype of lung cancer.

Tags: LungCancer, TargetedTherapy, Genetics

  • Scientists at Dana-Farber and the University of Colorado Cancer Center report on a gene fusion that spurs the cells to divide rapidly. 

Tags: BasicResearch, Genomics, LungCancer

  • Dr. Pasi Janne comments on his study showing a new cancer drug that significantly delayed the worsening of a form of lung cancer compared with traditional chemotherapy. (Full article requires a subscription)

Tags: BasicResearch, LungCancer

  • Dr. Bruce E. Johnson commented on the health threat of secondhand smoke.

Tags: LungCancer

  • Dr. Gabriel Brooks commented on a new study showing Medicare spending for patients with advanced cancer is not linked to differences in survival.

Tags: BreastCancer, ColonCancer, LungCancer, PancreaticCancer, ProstateCancer, Survivorship

  • A new study led by Dr. Suzanne Dahlberg shows lung cancer outcomes are better in obese patients early on, but obesity is linked to an overall higher risk of death.

Tags: BasicResearch, LungCancer

  • Dr. Leena Gandhi reported at the AACR meeting on a study showing a cancer immunotherapy that passed a key test in patients with lung cancer.

Tags: LungCancer

  • Dr. Pasi Jänne and colleagues found that more than half of lung and colon cancer patients may benefit from high-speed tests that detect DNA flaws doctors can target with existing medicines.

Tags: ColonCancer, Genomics, LungCancer

Showing 1-10 of 18 items